Vanberra Signal

BERG Health

Curated by Signal

Diagnostics, theranostics & therapeutics using proprietary drug discovery platform

Overview

Berg health is engaged in the research and development of diagnostics, theranostics, and therapeutics in the areas of oncology, endocrinology, and neurology. It is using its own Interrogative Biology & platform for research which is a combination of systems biology and Artificial Intelligence. It is evaluating BPM 31510 as a single agent and in combination with gemcitabine, 5FU, or docetaxel in patients with advanced refractory solid tumors. Also evaluating if topical Calcitriol (BPM 31543) is effective in preventing and/or diminishing chemotherapy-induced alopecia. It is developing diagnostic assays for prostate cancer and heart failure. It is discovering drugs for Parkinson, Alzheimer's, Diabetes, and Solid Tumors.

Key facts

Founded
2006

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of a portable platform for biomarker detection

    Life Sciences TechnologyIrvine, United States
  • AI-based personalized cancer diagnostics and treatment solutions

    Life Sciences TechnologyPhoenix, United States
  • Auditory enrichment software

    Life Sciences TechnologyFishers, United States

About BERG Health

What does BERG Health do?

Berg health is engaged in the research and development of diagnostics, theranostics, and therapeutics in the areas of oncology, endocrinology, and neurology.

Where is BERG Health headquartered?

BERG Health is headquartered in Framingham, United States.

When was BERG Health founded?

BERG Health was founded in 2006.

Which sector is BERG Health in?

BERG Health operates in Life Sciences Technology.

Who are BERG Health's competitors?

Companies similar to BERG Health include Fluxergy, Canary, and BabyPlus.